Creation of Porous Fibers for Adsorbing Pathogenic Substances in Intractable Diseases
NQ Score
51/100
Key facts
- Creation of Porous Fibers for Adsorbing Pathogenic Substances in Intractable Diseases
- Toray Industries has developed technology to control the pore size of PMMA porous fibers up to 1,000nm. This enables selective removal of large-molecular-weight pathogenic substances for intractable diseases. The company aims for early practical application in blood purification therapies.
- Source: PR TIMES
- Date: Sat Mar 28 2026 02:59:11 GMT+0900 (Japan Standard Time)
Direct answer
Toray Industries has developed technology to control the pore size of PMMA porous fibers up to 1,000nm. This enables selective removal of large-molecular-weight pathogenic substances for intractable diseases. The company aims for early practical application in blood purification therapies.
- Citation
- Creation of Porous Fibers for Adsorbing Pathogenic Substances in Intractable Diseases (Sat Mar 28 2026 02:59:11 GMT+0900 (Japan Standard Time)), PR TIMES
- Source
- PR TIMES
- Date
- Sat Mar 28 2026 02:59:11 GMT+0900 (Japan Standard Time)
AI Summary (NQ-processed)
Toray Industries has developed technology to control the pore size of PMMA porous fibers up to 1,000nm. This enables selective removal of large-molecular-weight pathogenic substances for intractable diseases. The company aims for early practical application in blood purification therapies.
AI analysis data is not yet available.
Frequently Asked Questions
- Q: What is the key feature of the developed fibers?
- A: They allow for arbitrary control of pore size up to 1,000nm while maintaining fiber strength, enabling selective adsorption of large-molecular-weight pathogenic substances.
- Q: What are the main applications?
- A: They are aimed at being used as a new blood purification treatment option for intractable diseases such as autoimmune disorders and cancer.
- Q: What are the key facts in this article?
- A: Toray Industries has developed technology to control the pore size of PMMA porous fibers up to 1,000nm. This enables selective removal of large-molecular-weight pathogenic substances for intractable diseases. The company aims for early practical application in blood purification therapies.